Psychotropic Drug Use in Psychiatric Inpatients: Recent Trends in Dosage and Choice of Psychotropic Drug in 3 German Speaking Countries

2005 ◽  
Vol 38 (01) ◽  
Author(s):  
A Konstantinidis ◽  
R Grohmann ◽  
A Horvath ◽  
S Kasper
Keyword(s):  
Drug Use ◽  
Psychotropic Drug ◽  
Psychiatric Inpatients ◽  
Psychotropic Drug Use ◽  
German Speaking ◽  
Recent Trends

Corrigendum to “Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use”

2003 ◽  
Vol 73 (3) ◽  
pp. 301-302 ◽  
Author(s):  
William T. Regenold ◽  
Ramesh K. Thapar ◽  
Christopher Marano ◽  
Sridevi Gavirneni ◽  
Prasad V. Kondapavuluru
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Drug Use ◽  
Psychotropic Drug ◽  
Psychiatric Inpatients ◽  
Schizoaffective Disorders ◽  
Psychotropic Drug Use

Guide Addresses Psychotropic Drug Use in Kids

2009 ◽  
Vol 39 (18) ◽  
pp. 32
Author(s):  
JOYCE FRIEDEN
Keyword(s):  
Drug Use ◽  
Psychotropic Drug ◽  
Psychotropic Drug Use

Clozapine and excessive psychotropic drug use

1996 ◽  
Vol 47 (8) ◽  
pp. 876a-876
Keyword(s):  
Drug Use ◽  
Psychotropic Drug ◽  
Psychotropic Drug Use

Side Effects on Fetus and Infant of Psychotropic Drug Use during Pregnancy

1976 ◽  
Vol 11 (4) ◽  
pp. 246-260 ◽  
Author(s):  
J. Ananth
Keyword(s):  
Side Effects ◽  
Drug Use ◽  
Psychotropic Drug ◽  
Psychotropic Drug Use

scholarly journals Are There Racial Disparities in Psychotropic Drug Use and Expenditures in a Nationally Representative Sample of Men in the United States? Evidence From the Medical Expenditure Panel Survey

2013 ◽  
Vol 8 (1) ◽  
pp. 82-90 ◽  
Author(s):  
Geraldine Pierre ◽  
Roland J. Thorpe ◽  
Gniesha Y. Dinwiddie ◽  
Darrell J. Gaskin
Keyword(s):  
United States ◽  
Drug Use ◽  
Racial Disparities ◽  
Psychotropic Drug ◽  
Medical Expenditure Panel Survey ◽  
The United States ◽  
Medical Expenditure ◽  
Panel Survey ◽  
Psychotropic Drug Use ◽  
Nationally Representative

This article sought to determine whether racial disparities exist in psychotropic drug use and expenditures in a nationally representative sample of men in the United States. Data were extracted from the 2000-2009 Medical Expenditure Panel Survey, a longitudinal survey that covers the U.S. civilian noninstitutionalized population. Full-Year Consolidated, Medical Conditions, and Prescribed Medicines data files were merged across 10 years of data. The sample of interest was limited to adult males aged 18 to 64 years, who reported their race as White, Black, Hispanic, or Asian. This study employed a pooled cross-sectional design and a two-part probit generalized linear model for analyses. Minority men reported a lower probability of psychotropic drug use (Black = −4.3%, 95% confidence interval [CI] = [−5.5, −3.0]; Hispanic = −3.8%, 95% CI = [−5.1, −2.6]; Asian = −4.5%, 95% CI = [−6.2, −2.7]) compared with White men. After controlling for demographic, socioeconomic, and health status variables, there were no statistically significant race differences in drug expenditures. Consistent with previous literature, racial and ethnic disparities in the use of psychotropic drugs present problems of access to mental health care and services.

scholarly journals Psychotropic drug use among people with dementia – a six-month follow-up study

2013 ◽  
Vol 14 (1) ◽  
Author(s):  
Maria Gustafsson ◽  
Stig Karlsson ◽  
Yngve Gustafson ◽  
Hugo Lövheim
Keyword(s):  
Drug Use ◽  
Psychotropic Drug ◽  
Follow Up Study ◽  
Psychotropic Drug Use ◽  
People With Dementia

scholarly journals Incarceration and Psychotropic Drug Use by Youth

2008 ◽  
Vol 162 (3) ◽  
pp. 219 ◽  
Author(s):  
Alison Evans Cuellar ◽  
Kelly J. Kelleher ◽  
Sheryl Kataoka ◽  
Steven Adelsheim ◽  
Joseph J. Cocozza
Keyword(s):  
Drug Use ◽  
Psychotropic Drug ◽  
Psychotropic Drug Use
Sign in / Sign up

Export Citation Format

Share Document